home / stock / abvc / abvc news

ABVC News and Press, ABVC BioPharma Inc. From 08/17/23

Stock Information
Company Name: ABVC BioPharma Inc.
Stock Symbol: ABVC
Market: NASDAQ
Website: abvcpharma.com
Menu
ABVC ABVC Quote ABVC Short ABVC News ABVC Articles ABVC Message Board
Get ABVC Alerts

News, Short Squeeze, Breakout and More Instantly...
ABVC - ABVC Executes Cooperation Agreement for Strategic Investments

FREMONT, CA - ( NewMediaWire ) - August 17, 2023 -   ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in Oncology/Hematology, Neurology, and Ophthalmology, announced today that it had entered into a Cooperation Agr...
ABVC - ABVC BioPharma regains compliance with Nasdaq's minimum bid price requirement

2023-08-10 10:23:27 ET Clinical-stage biopharmaceutical firm ABVC BioPharma ( NASDAQ: ABVC ) Thursday said it received a letter from Nasdaq notifying that company had regained compliance with the minimum bid price requirement. The closing bid price of ABVC's common stock was a...

ABVC - ABVC BioPharma Regains Compliance With Nasdaq's Minimum Bid Price Requirement

FREMONT, CA - ( NewMediaWire ) - August 10, 2023 - Fremont, CA - ( NewMediaWire ) - August 10, 2023 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, neurology, and oncology/hematology, ...

ABVC - ABVC Corporate Update and CEO's Letter to Shareholders

FREMONT, CA - ( NewMediaWire ) - August 07, 2023 -   ABVC BioPharma, Inc.  (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, neurology, and oncology/hematology, today published a  Corporate Update and...
ABVC - ABVC Announces the Approval of the Plan for GMP Production Facilities of Vitargus by Taiwan Science Park Administration

FREMONT, CA - ( NewMediaWire ) - August 3, 2023 - ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company specializing in therapeutic solutions in oncology/hematology, neurology, and ophthalmology, announced that the Science Park Administration in Taiwan approved th...

ABVC - ADMP, TIGR and TMC among pre-market losers

2023-08-02 08:33:20 ET Adamis Pharmaceuticals Corporation ( ADMP ) -38% . Cambium Networks Corporation CMBM -31% after Q2 earning release . Evolve Transition Infrastructure LP ( OTC:SNMP ) -29% . Latch ( LTCH ) -29% . Driven Brands Holdings ...

ABVC - ABVC stock rallies on Chinese licensing deal for psych drugs

2023-08-01 14:10:15 ET ABVC BioPharma ( NASDAQ: ABVC ) stock shot up as much as 100% Tuesday following news that it has entered into a tentative licensing deal to develop its psychiatric drug candidates ABV-1504 and ABV-1505 for the Chinese market. Shares of ABVC were up 42% at ...
ABVC - SILV, TUP and RYTM among mid-day movers

2023-08-01 13:16:16 ET Gainers: Motorsport Games ( MSGM ) +86% . Yellow Corporation ( YELL ) +65% . ABVC BioPharma ( ABVC ) +51% . American Superconductor Corporation ( AMSC ) +50% . Evolve Transition Infrastructure LP ( OTC:SNMPD ) ...

ABVC - Adamis, ABVC top healthcare gainers; TG Therapeutics, Invo among losers

2023-08-01 10:04:48 ET Gainers: Adamis Pharmaceuticals ( ADMP ) +71% . ABVC BioPharma ( ABVC ) +49% . EQRx ( EQRX ) +18% . Rhythm Pharmaceuticals ( RYTM ) +17% . Esperion Therapeutics ( ESPR ) +6% . Losers: TG Therapeu...

ABVC - ABVC Signs a Term Sheet to Earn Licensing Fees of up to $20M and Royalties of 5-12% of Net Sales

FREMONT, CA - ( NewMediaWire ) - August 01, 2023 - ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, neurology, and ophthalmology, today announced the signing of a legally binding term sheet with a promin...
Previous 10 Next 10